Pfizer Inc. discovers develops manufactures markets distributes and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas including cardiovascular and migraine under the Eliquis Nurtec ODT/Vydura Zavzpret and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family Abrysvo Nimenrix FSME/IMMUN-TicoVac and Trumenba brands; and COVID-19 prevention and treatment and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz Enbrel Inflectra Litfulo Velsipity and Cibinqo brands; amyloidosis hemophilia endocrine diseases and sickle cell disease under the Vyndaqel family Oxbryta BeneFIX Somavert Ngenla and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon Medrol Zavicefta Zithromax Octagam and Panzyga brands; and biologics small molecules immunotherapies and biosimilars under the Ibrance Xtandi Padcev Adcetris Inlyta Lorbrena Bosulif Tukysa Braftovi Mektovi Orgovyx Elrexfio Tivdak and Talzenna brands. In addition the company involved in the contract manufacturing business. It serves wholesalers retailers hospitals clinics government agencies pharmacies individual provider offices retail pharmacies and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. has strategic collaboration with Boltz PBC to develop and deploy state-of-the-art biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York New York.